221 related articles for article (PubMed ID: 33888849)
1. Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens.
Xiang R; Ma L; Yang M; Zheng Z; Chen X; Jia F; Xie F; Zhou Y; Li F; Wu K; Zhu Y
Commun Biol; 2021 Apr; 4(1):496. PubMed ID: 33888849
[TBL] [Abstract][Full Text] [Related]
2. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
[TBL] [Abstract][Full Text] [Related]
3. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
Wen B; Li K; Zhang Y; Zhang B
Nat Commun; 2020 Apr; 11(1):1759. PubMed ID: 32273506
[TBL] [Abstract][Full Text] [Related]
4. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.
Polyakova A; Kuznetsova K; Moshkovskii S
Expert Rev Proteomics; 2015; 12(5):533-41. PubMed ID: 26175083
[TBL] [Abstract][Full Text] [Related]
6. Proteogenomic discovery of cancer antigens: Neoantigens and beyond.
Kanaseki T; Tokita S; Torigoe T
Pathol Int; 2019 Sep; 69(9):511-518. PubMed ID: 31397525
[TBL] [Abstract][Full Text] [Related]
7. BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.
Cuevas MVR; Hardy MP; Larouche JD; Apavaloaei A; Kina E; Vincent K; Gendron P; Laverdure JP; Durette C; Thibault P; Lemieux S; Perreault C; Ehx G
Genome Biol; 2023 Aug; 24(1):188. PubMed ID: 37582761
[TBL] [Abstract][Full Text] [Related]
8. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
9. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy.
Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168
[TBL] [Abstract][Full Text] [Related]
10. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
11. Neoantigens encoded in the cancer genome.
Schumacher TN; Hacohen N
Curr Opin Immunol; 2016 Aug; 41():98-103. PubMed ID: 27518850
[TBL] [Abstract][Full Text] [Related]
12. Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Tretter C; de Andrade Krätzig N; Pecoraro M; Lange S; Seifert P; von Frankenberg C; Untch J; Zuleger G; Wilhelm M; Zolg DP; Dreyer FS; Bräunlein E; Engleitner T; Uhrig S; Boxberg M; Steiger K; Slotta-Huspenina J; Ochsenreither S; von Bubnoff N; Bauer S; Boerries M; Jost PJ; Schenck K; Dresing I; Bassermann F; Friess H; Reim D; Grützmann K; Pfütze K; Klink B; Schröck E; Haller B; Kuster B; Mann M; Weichert W; Fröhling S; Rad R; Hiltensperger M; Krackhardt AM
Nat Commun; 2023 Aug; 14(1):4632. PubMed ID: 37532709
[TBL] [Abstract][Full Text] [Related]
13. A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients.
Koster J; Plasterk RHA
Sci Rep; 2019 Apr; 9(1):6577. PubMed ID: 31036835
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomics: advances in cancer antigen research.
Kanaseki T; Torigoe T
Immunol Med; 2019 Jun; 42(2):65-70. PubMed ID: 31318319
[TBL] [Abstract][Full Text] [Related]
15. Discovery of coding regions in the human genome by integrated proteogenomics analysis workflow.
Zhu Y; Orre LM; Johansson HJ; Huss M; Boekel J; Vesterlund M; Fernandez-Woodbridge A; Branca RMM; Lehtiö J
Nat Commun; 2018 Mar; 9(1):903. PubMed ID: 29500430
[TBL] [Abstract][Full Text] [Related]
16. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
17. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
Leoni G; D'Alise AM; Cotugno G; Langone F; Garzia I; De Lucia M; Fichera I; Vitale R; Bignone V; Tucci FG; Mori F; Leuzzi A; Di Matteo E; Troise F; Abbate A; Merone R; Ruzza V; Diodoro MG; Yadav M; Gordon-Alonso M; Vanhaver C; Panigada M; Soprana E; Siccardi A; Folgori A; Colloca S; van der Bruggen P; Nicosia A; Lahm A; Catanese MT; Scarselli E
Cancer Res; 2020 Sep; 80(18):3972-3982. PubMed ID: 32690723
[TBL] [Abstract][Full Text] [Related]
18. Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade.
Richman LP; Vonderheide RH; Rech AJ
Cell Syst; 2019 Oct; 9(4):375-382.e4. PubMed ID: 31606370
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides.
Bonté PE; Arribas YA; Merlotti A; Carrascal M; Zhang JV; Zueva E; Binder ZA; Alanio C; Goudot C; Amigorena S
Cell Rep; 2022 Jun; 39(10):110916. PubMed ID: 35675780
[TBL] [Abstract][Full Text] [Related]
20. Neoantigen vaccine: an emerging tumor immunotherapy.
Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
